As the outbreak of COVID-19 widens, our specialists are sharing their knowledge and expertise regarding the novel coronavirus. The Mount Sinai Health System is committed to bringing you the latest news, knowledge, and treatment strategies for COVID-19—vetted by infectious disease specialists and other health care experts.
Some of the specialized patient populations whose needs we address include Geriatrics, OB/GYN, and transplant patients. Our trusted experts bring you information that is practical and useful to your patients. Check back frequently, as our content is constantly being updated.
Patient Resources
Mount Sinai Experts Explain What the Omicron Variant Means for You
Currently, there is insufficient data on how easily the Omicron variant may be transmitted or whether it produces more serious illness.
COVID-19 Cases Have Been Rising. Here’s What You Need to Know.
The New York City Department of Health and Mental Hygiene reports hospitalizations in New York surged in July, but the number is still a small fraction of what it was in January of 2022 during the last big surge.
The Center for Post-COVID Care at Mount Sinai
It was initially thought that patients with COVID-19 fell into two groups: those who experience severe symptoms and require hospitalization.
What Is the Latest Omicron Subvariant, and Why Does It Matter?
Headlines are appearing about a new version of the COVID-19 virus—a new type of the Omicron variant called a subvariant.
If I'm Pregnant, Should I Get The COVID-19 Vaccine?
Joanne Stone, MD, MS, Director of Maternall Fetal Medicine answers frequently asked patient questions about the COVID-19 vaccine and pregnancy
Mount Sinai Actively Recruits Volunteers From Hardest-Hit Communities for COVID-19 Vaccine Trial
As Mount Sinai participates in the Pfizer clinical trial for a COVID-19 vaccine, program leadership is making sure that people of color are represented
Returning Back to School Safely During COVID-19
Aliza Pressman, PhD, shares tips for parents on how to manage their children’s anxiety, as well as their own, as children return to school during #COVID19
Men Hospitalized for COVID-19 Were Younger and Healthier Than Women Who Were Hospitalized
A Mount Sinai study analyzed the electronic health records of hospitalized patients to examine the risk factors of gender, health, and inflammation.
Keeping Patients Safe: A Message to Our Urology Patients
Mount Sinai is taking many precautions during the COVID-19 pandemic to keep patients safe who need urological care. Ashutosh Tewari, MBBS, MCh, discusses what patients can expect
World Hepatitis Awareness Day: Current Trends in Treatment
Douglas Dieterich, MD, discusses how hepatitis prevention and treatment have evolved over the years.
Keeping Patients Safe: A Message to Our Orthopedics Patients
Leesa M. Galatz, MD, discusses the precautions and protocols for patients seeking orthopedic care during COVID-19
Returning to Health Care: Starting With the Kids
Pediatric care at Mount Sinai since COVID-19, and what parents should know about health management for their kids.
Safety at Mount Sinai Kravis Children’s Heart Center
Robert Pass, MD, Co-Director of the Mount Sinai Kravis Children’s Heart Center, outlines all the precautions taken to ensure the safety of our patients.
Down Syndrome May Intensify COVID-19 Symptoms
Study finds that people with Down syndrome may experience severe forms of COVID-19.
Lessons From the Epicenter: What We Have Learned About COVID-19
Physicians and researchers discuss the effects, biology, and treatment of COVID-19, knowledge gained during the course of treating more than 8,000 patients at Mount Sinai.
Keeping Patients Safe: A Message to Our Neurosurgery Patients
Experts from the Mount Sinai Department of Neurosurgery discuss what patients should expect—and why they shouldn’t put off treatment during COVID-19
Jonas Family Donation Supports Pediatric Research Into COVID-19
The gift is supporting research into multi-system inflammatory syndrome in children recovering from COVID-19.
Can I Receive Mental Health Care While Social Distancing?
Claire Jackson-Rabinowitz, DO, discusses what to expect from, as well as the benefits of, a telepsychiatric appointment during COVID-19.
Speech and Language Analysis for COVID-19
Cheryl Corcoran, MD, discusses how speech and language markers can be used to track physiology and psychiatric sequelae related to COVID-19 course together with other variables and biomarkers.
Managing Diabetes and Healthy Eating During COVID-19
Maria Peña, MD, discusses managing diabetes and eating healthier during COVID-19.
Large-Vessel Stroke and COVID-19 in Young Patients: New Insights
Cerebrovascular stroke specialists highlight findings published in The New England Journal of Medicine.
COVID-19: Impact on Melanoma Patients
What melanoma patients can expect from their telemedicine appointment during COVID-19.
Reshmi Srinath, MD, provides useful information for patients with diabetes regarding COVID-19.
Seeking Care for Hearing Loss During COVID-19
George Wanna, MD, FACS, offers advice for patients seeking care for hearing loss during COVID-19
COVID-19: Supporting Individuals With Autism During Social Distancing
Insights to help individuals with autism manage anxiety, daily routines, and socialization.
Satish Govindaraj, MD, discusses the spectrum of sinus conditions and COVID-19.
Monitoring to Rapidly Respond to COVID-19
A new remote monitoring platform developed by the Mount Sinai Health System is helping health care providers to care for COVID-19 patients who are recovering at home.
COVID-19: Information for Patients with Gynecological Cancer
Stephanie V. Blank, MD, answers commonly asked questions by patients with gynecological cancer regarding COVID-19.
A podcast that brings you stories and insights to help you thrive in a challenging world.
How Epidemics Affect Our Mental Health
Craig Katz, MD, Director of Mount Sinai’s Global Mental Health Program, delivers a Grand Rounds presentation on the behavioral sequelae of epidemics.
How to Be a Good Parent During COVID-19
Aliza W. Pressman, PhD, addresses the challenges of parenting during the COVID-19 outbreak.
COVID-19: Impact on Eye Health
Gareth M.C. Lema, MD, PhD, answers questions regarding COVID-19 transmission through the eyes, and other eye-health concerns.
COVID-19: Effects on Senses of Taste and Smell
Alfred-Marc Iloreta, Jr., MD, discusses COVID-19 and its effects on sense of smell and taste.
COVID-19: Fever Reduction Facts
Jonathan Schimmel, MD, discusses fever reduction and the use of ibuprofen for COVID-19.
What Older Adults Need to Know About COVID-19
R. Sean Morrison, MD, offers common-sense guidance for older adults and their loved ones regarding COVID-19
COVID-19: Implications on Inflammatory Bowel Disease
COVID-19: Implications on Inflammatory Bowel Disease
Valentín Fuster, MD, PhD, offers calming advice for heart patients, as well as guidelines for preventing and seeking care for COVID-19.
COVID-19: Social Distancing for Older Adults
R. Sean Morrison, MD, explains why social distancing is essential for older adults—and how to practice it safely.
COVID-19 and What Multiple Myeloma Patients Need to Know
Treating Multiple Myeloma in the Midst of COVID-19
COVID-19: What Cancer Patients Need to Know
Cardinale B. Smith, MD, PhD, provides advice, tips, and information about COVID-19, specific to needs of cancer patients
COVID-19: Answers to Your Pregnancy Questions
Frederick Friedman, Jr., MD, answers the concerns of pregnant women about COVID-19
COVID-19: What Transplant Patients Need to Know
Meenakshi M. Rana, MD, shares guidance for transplant patients whose immune systems may be susceptible to COVID-19
COVID-19: Impact on Respiratory Conditions
Louis R. DePalo, MD, on COVID-19 and the specific concerns of respiratory patients
Physician Resources
The Unusual Protective Properties of SARS-CoV-2 in People With Asthma
Mount Sinai researchers are exploring the finding that certain proteins produced by patients with mild to moderate eosinophilic asthma downregulate the angiotensin-converting enzyme 2 receptor that allows SARS-CoV-2 entry to airway cells, ...
A long-term analysis conducted by leading microbiologists at the Icahn School of Medicine at Mount Sinai reveals that antibody responses induced by COVId-19 vaccines are long-lasting.
The Future Of COVID-19 Vaccine Development
“There is a continued need for vigilance, research, prevention, and proactive strategies.”
Long COVID patients have clear differences in immune and hormone function from patients without the condition, according to a new study led by the Icahn School of Medicine at Mount Sinai and Yale School of Medicine.
Reduced Hospitalizations and Mortality Rates Among COVID-19-Vaccinated Patients With Heart Failure
The study is the first to look at COVID-19 vaccination status and outcomes in patients with heart failure and has indicated significant protective effects in this high-risk patient population.
Researchers from the Icahn School of Medicine at Mount Sinai have generated the first induced pluripotent stem cells (iPSCs) from bats, gaining valuable insights into the close relationship between bats and viruses.
People with Down syndrome have less frequent but more severe viral infections.
A team of Mount Sinai researchers has produced a high-resolution crystal structure of an enzyme essential to the survival of SARS-CoV-2, the virus that causes COVID-19.
A subset of blood cancer patients still remained vulnerable, needing fourth dose or antibody treatments
Three Prestigious Institutions Band Together Against Common Challenges
Mount Sinai Health System, Jefferson Health, and National Jewish Health have begun working together to advance understanding, diagnosis, and treatment of a range of pulmonary diseases, some of which have traditionally been orphan diseases.
Message From Mount Sinai Kravis Children’s Hospital Leadership
Over the past year, Mount Sinai Kravis Children’s Hospital has experienced tremendous growth and success in our missions of clinical care, research, and education, while continuing to navigate the challenges associated with the COVID-19 pandemic.
Promising Results in Trial of Artificial Pancreas System for Pregnant Women With Type 1 Diabetes
Mount Sinai is one of three U.S. sites participating in a clinical trial of an experimental “artificial pancreas” system customized for the stringent glucose targets recommended for optimal maternal and fetal outcomes of pregnancies complicated by diabetes.
Revised Approach to Managing “Pheo” Adrenal Tumors Is Developed During COVID-19 Pandemic
When the COVID-19 crisis forced New York hospitals to delay all non-urgent surgeries, clinicians at Mount Sinai’s Adrenal Center were able to safely manage three patients with newly diagnosed pheochromocytomas for longer than the recommended ...
COVID-19 in Early Pregnancy May Not Cause Harm, Study Finds
Research from a team at Mount Sinai provides reassurance that a SARS-CoV-2 infection in early pregnancy that has resolved by the time of delivery does not appear to adversely affect maternal or fetal outcomes.
Successful Cesarean Section for COVID-19 Patient on ECMO Support
Due to teamwork and technically advanced care at The Mount Sinai Hospital, a 33-year-old patient delivered a healthy baby through cesarean section while on ECMO life support for COVID-19 pneumonia.
A large study conducted by investigators at Mount Sinai and Reproductive Medicine Associates of New York found that vaccination against COVID-19 did not affect fertility outcomes in patients undergoing in-vitro fertilization.
Outline Provides Guidance for Management of Heart Failure Patients During COVID-19 Pandemic
A scientific statement outlining unique considerations and suggestions for managing heart failure patients during the COVID-19 pandemic was issued in September 2021 by the Heart Failure Society of America, and Anuradha Lala, MD, Assistant ...
Registry Tracks How IBD Drugs Interact With COVID-19
A research database known as SECURE-IBD provides a quick and robust source of information to clinicians around the world about the use of IBD therapies like corticosteroids and the widely prescribed tumor necrosis factor (TNF) antagonists ...
Intestinal Study Yields Insights Into Persistence of SARS-CoV-2
SARS-CoV-2 has a spike protein that tethers itself to angiotensin converting enzyme 2 (ACE2) to gain entry to cells, and the intestinal tract has the highest expression of ACE2 in the body—even higher than in the lungs.
Nationwide Study of 'Long COVID' Will Put Lungs Front and Center
Mount Sinai will serve as a hub site for two cohort studies as part of the NIH Researching COVID to Enhance Recovery (RECOVER) Initiative, which will assess the post-acute sequelae of SARS-CoV-2 infection (PASC).
Driven by COVID-19 Sequelae, Mount Sinai Establishes Lung Transplant Program
Mount Sinai Health System has recruited two world-renowned experts to establish a lung transplantation program that will care for both traditional and highly complex cases. The demand for these services is projected to grow as more patients ...
Moving Ahead: From COVID-19 to Lung Cancer Screening
From addressing the aftermath of COVID-19 to stepping up the fight against lung cancer, Mount Sinai’s Catherine and Henry J. Gaisman Division of Pulmonary, Critical Care and Sleep Medicine continues to move the field forward.
Mount Sinai leads international anticoagulation trial for answers on preventing clots in mild hospitalization cases
Stress, Resilience, and Digital Health Research in the Era of COVID-19
Mount Sinai has been on the forefront of trauma, stress, depression, and resilience research for decades. This virtual symposium covers the latest: what we know, and what we are learning that can equip us in addressing the pandemic’s psychological ...
COVID-19 Vaccines for IBD Patients: International Consensus
Researchers Identify a Promising New Antiviral Drug to Treat COVID-19
The search for better medical treatments for COVID-19 has led a team of scientists from the Icahn School of Medicine at Mount Sinai, with colleagues in San Francisco, to plitidepsin—a promising small molecule drug derived from a sea organism.
Adolfo García-Sastre, PhD, on Plitidepsin Clinical Efficacy Against SARS-CoV-2
In this video, Adolfo García-Sastre, PhD, describes the search to find drugs appropriate for repurposing against SARS-CoV-2 and the effectiveness of plitidepsin
COVID-19 Vaccine Update With Aaron E. Glatt, MD
July, 2020 - Aaron E. Glatt, MD, discusses the mechanisms of the leading COVID-19 vaccines, their efficacy, and adverse effects
mRNA Vaccine Technology Makes Its Extraordinary Debut
Learn about the history and technology of the new COVID-19 mRNA vaccines and the new low-cost vaccine under development at the Icahn School of Medicine at Mount Sinai.
COVID-19 Vaccines and Treatments: An Inside Look at What Lies Ahead
Gain an overview of the race to develop vaccines and treatments from Mount Sinai experts
The Efficacy of Blood Thinners for COVID-19 and Best Potential Regimens
Mount Sinai researchers provide additional data on the efficacy of anticoagulants and insight into the best potential regimens.
Judith Aberg, MD, discusses convalescent plasma research for the prevention and treatment of COVID19.
Men Hospitalized for COVID-19 Were Younger and Healthier Than Women Who Were Hospitalized
A Mount Sinai study analyzed the electronic health records of hospitalized patients to examine the risk factors of gender, health, and inflammation.
Dilated Blood Vessels in the Lung May Explain Low Oxygen Levels in Severe Cases of COVID-19
A new pilot study from Mount Sinai suggests that COVID-19 is causing significant dilation of the blood vessels of the lung, specifically the capillaries.
Five Things to Know About Providing Psychiatric Care to COVID-19 Heath Care Workers
Health care workers will likely be facing significant mental health consequences due to their involvement with COVID-19. Check out the top five things to know about providing psychiatric care to these health care workers during and after the pandemic.
Most People With COVID-19 Mount a Strong Antibody Response That Lasts
Researchers at the Icahn School of Medicine at Mount Sinai determine that immune response to COVID-19 lasts months.
World Hepatitis Awareness Day: Current Trends in Treatment
Douglas Dieterich, MD, discusses how hepatitis prevention and treatment have evolved over the years.
Mount Sinai Partners to Develop COVID-19 Hyperimmune Globulin
Mount Sinai Health System, Emergent BioSolutions, and ImmunoTek Bio Centers form a collaboration to develop Emergent’s COVID-19 hyperimmune globulin with U.S. Department of Defense funding.
Will my Patients be separated from COVID-19 Patients?
Benjamim J. Golas, MD, Chief of Surgical Oncology, discusses safetyprecautions and protocols.
Telemedicine As An Option for Cancer Treatment
Benjamin J. Golas, MD, Chief of Surgical Oncology, discusses the role of telemedicine in treating cancer patients.
Should Patients Wait To Receive Cancer Treatment?
Benjamin J. Golas, MD, discusses why patients shouldn’t wait to seek treatment for cancer during the COVID-19 pandemic.
Can Patients Receive Cancer Surgery in the COVID-19 Era?
With the approval of New York State, surgeries have recommenced. Benjamin J. Golas, MD, discusses the special precautions for cancer patients scheduled for surgery.
Safety Protocols In The Department of Surgery
Benjamin J. Golas, MD, Chief of Surgical Oncology, reviews the practices in place to ensure patient safety.
Protocols To Protect Patients From COVID-19 Who Need Surgery
Michael Marin, MD, Surgeon-in-Chief of the Mount Sinai Health System discusses precautions we’re taking to protect patients who need surgery from COVID-19.
Protecting Patients From COVID-19 After Surgery
Michael Marin, MD, Surgeon-in-Chief of the Mount Sinai Health System, discusses the precautions we take to ensure patient safety after surgery.
Mount Sinai Receives $6.3 Million Federal Grant to Fight COVID-19
Researchers from the Icahn School of Medicine at Mount Sinai are working to identify FDA-approved drugs that can be repurposed to prevent or treat COVID-19
The Mount Sinai Center for Stress, Resilience and Personal Growth
Mental health experts from Mount Sinai discuss the stress on front-line workers due to COVID-19 and the creation of the Center.
Down Syndrome May Intensify COVID-19 Symptoms
Study finds that people with Down syndrome may experience severe forms of COVID-19.
Lessons From the Epicenter: What We Have Learned About COVID-19
Physicians and researchers discuss the effects, biology, and treatment of COVID-19, knowledge gained during the course of treating more than 8,000 patients at Mount Sinai.
Going Above and Beyond: Mount Sinai Nursing Students During COVID-19
How a small force of Mount Sinai nursing students played key support roles at the height of COVID-19.
Research Confirms Antibody Response to COVID-19 in Mild to Moderate Cases
Researchers at the Icahn School of Medicine at Mount Sinai find that recovered COVID-19 patients almost always have an antibody response, even among mild to moderate cases.
Explanation for Reduced MI During COVID-19 Pandemic
Samin K. Sharma, MD, discusses whether acute vascular illnesses are reduced or under-reported during COVID-19.
Case Study: Atypical Presentation and Delayed Diagnosis of COVID-19
Timothy Harkin, MD, describes a case study published in The Lancet of atypical presentation of COVID-19.
Applying Informatics to Fight COVID-19
Learn how the Mount Sinai COVID Informatics Center is harnessing the power of data to fight COVID-19
The Impact of COVID-19 on Mothers and Babies
Veerle Bergink, MD, PhD, discusses mental health during pregnancy and the postpartum period during COVID-19, including potential long-term effects on the child’s brain.
Speech and Language Analysis for COVID-19
Cheryl Corcoran, MD, discusses how speech and language markers can be used to track physiology and psychiatric sequelae related to COVID-19 course together with other variables and biomarkers.
An Overview of Current Medication Responses to COVID-19
A Mount Sinai panel discusses the effectiveness of hydroxychloroquine, remdesivir, and antibody therapy, among others.
COVID-19 and Employee Mental Health: A Five-Tier Model of Support
New York City is an epicenter of COVID-19 pandemic in the United States, and the Mount Sinai Health System has spearheaded an array of clinical and organizational innovations to mitigate the crisis.
COVID-19: Thrombotic Complications and Therapy
Our panel of Mount Sinai experts discuss effective patient evaluation, management, and antithrombotic strategies for COVID-19
The Department of Neurosurgery Global TeleRounds features a discussion on social media and neurosurgery.
Large-Vessel Stroke and COVID-19 in Young Patients: New Insights
Cerebrovascular stroke specialists highlight findings published in The New England Journal of Medicine.
STOP COVID NYC: A Study Capturing City-Wide Coronavirus Symptoms and Mental Health Impacts
Laura Huckins, PhD, Assistant Professor of Psychiatry, and Genetics and Genomic Sciences, discusses a new app-based survey gathering data on New York City residents and their COVID-19-related symptoms in order to better understand transmission ...
Anticoagulation Associated With Improved Outcomes in Hospitalized COVID-19 Patients
In this study published by the ACC, researchers analyzed the association between in-hospital anticoagulation administration and mortality among patients hospitalized with COVID-19.
COVID-19 Pandemic: Opportunities Lost and Lessons Learned, Part III
A cross-disciplinary panel discusses the effect COVID-19 has on organs throughout the body, and lessons learned during the outbreak in New York.
Racial Disparity in the Incidence of COVID-19
Lynne D. Richardson, MD, discusses social, medical, and economic factors that contribute to the higher risk for African American and Latino populations.
Important Vascular Medicine Concepts for the Cardiologist
An illustration of diagnostic inquiry with three case presentations.
Students, Postdoctoral Fellows, and Faculty Team Up to Advance Immunology Research on COVID-19
Members of the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai have formed a group to review the unprecedented generation of non-peer-reviewed scientific information about COVID-19.
COVID-19: Antibodies and Vaccine
An overview of the current approaches to vaccine development for COVID-19
Mount Sinai Develops ‘Pseudo Virus’ to Assess the Effectiveness of Antibodies
A team of microbiologists at the Icahn School of Medicine at Mount Sinai led by Benhur Lee, MD, have developed an assay that tests the quality of an individual’s antibodies to see whether they strongly neutralize the SARS-CoV-2 virus.
Challenging Electrophysiology Cases During COVID-19
Watch two case presentations and an overview of research on COVID-19 and electrophysiology.
COVID-19: Information for Transgender Patients
Joshua Safer, MD, discusses the ongoing health care needs of transgender patients during COVID-19.
CNN Interview: Florian Krammer, PhD, Discusses Antibodies, Immunity, and COVID-19
Florian Krammer, PhD, is interviewed by Anderson Cooper about COVID-19 and antibodies.
Navigating Surgery in the Time of COVID-19
Linda P. Zhang, MD, discusses the reopening and future of surgical practices as COVID-19 subsides.
COVID-19: Impact on Chronic Kidney Disease and Dialysis
Samira Farouk, MD, discusses the relationship between COVID-19 and the need for kidney treatment.
COVID-19: The Impact on Neurosurgery
A Presentation from the Mount Sinai Department of Neurosurgery Global TeleRounds
Mount Sinai’s Antibody Test for COVID-19 Receives Emergency Use Authorization from FDA
A renowned team of virologists, pathologists, and clinicians at the Mount Sinai Health System developed, validated, and launched a blood test for COVID-19 antibodies that received the U.S. Food and Drug Administration’s (FDA) emergency ...
How Students Can Cope With COVID-19
Rachel Colon, LCSW, addresses the many issues that students are facing due to COVID-19.
COVID-19: Update and Safety for the Public and Health Care Workers
Eric M. Genden, MD, MHCA, FACS, provides insights on COVID-19 prevention for daily life.
COVID-19: Impact on Stroke and Stroke Patients
J Mocco, MD, discusses the possible relationship between COVID-19 and stroke.
COVID-19: Developing the Mount Sinai Antibody Test
COVID-19: Developing the Mount Sinai Antibody Test
Treating Myeloma During the COVID-19 Crisis
Joshua Richter, MD, provides guidance on multiple myeloma treatment during COVID-19.
COVID-19: IBD Update From the Front Lines
A new database tracks risk factors for IBD patients who have COVID-19
Study Leads to New Questions About the Disease Progression of COVID-19 in the Lungs
A small, preliminary case series led by physicians at the Icahn School of Medicine at Mount Sinai found that five severely ill patients with the SARS-CoV-2 virus responded to the blood-clot-busting drug tPA when it was introduced as a life-saving measure.
Regional Neurosurgeons Provide Insights on Mobilizing for COVID-19
A Presentation from the Mount Sinai Department of Neurosurgery Global TeleRounds
COVID-19: Precision Recovery Patient
A COVID-19 patient describes how the remote monitoring app “Precision Recovery” helped him recover.
Endotracheal Intubation for the COVID-19 Patient
Mark Shehata, MD, covers the pre- and post-intubation steps that are unique to the COVID-19 patient.
Overview of Critical Care Management of COVID-19 Patients in the ICU
From staffing to procedures, Adel M. Bassily-Marcus, MD, provides an overview of COVID-19 case management in the ICU.
Prone Positioning for the COVID-19 Patient
Divya Sreeramoju, MD, discusses procedures before, during, and after proning for maximum patient safety.
Perspectives on COVID-19 from the Mount Sinai Department of Neurosurgery
Experts discuss the neurological manifestations of COVID-19 and its impact on the Mount Sinai Health System.
A team of pulmonologists, anesthesiologists, sleep and critical care specialists, and medical students at the Mount Sinai Health System are reconfiguring hundreds of donated machines that are typically used at home for sleep apnea and ...
Mount Sinai Uses Remote Patient Monitoring to Rapidly Respond to COVID-19
An app developed by Mount Sinai provides daily monitoring and timely intervention for COVID-19.
SARS-CoV2: How a Low-Powered Virus Turns Deadly
Benjamin R. tenOever, PhD, describes the stealthy attack of SARS-CoV2 on the immune system.
The First Intercontinental Grand Rounds: The Department of Neurosurgery at Mount Sinai and COVID-19
Neurosurgeons from around the world discuss the impact of COVID-19 on their institutions.
Controlling Extreme Inflammation in Severe Cases of COVID-19 May Save Lives
Miriam Merad, MD, PhD, introduces a test for inflammation that may be able to guide treatment for COVID-19.
How to Use Psychological First Aid to Prevent Post-Disaster Psychopathology
Craig Katz, MD, Director of Mount Sinai’s Program in Global Mental Health, breaks down how to deliver psychological first aid in a disaster setting in order to prevent post-disaster psychopathology.
COVID-19 Antibodies Aid Critically Ill Patients
Mount Sinai initiates procedure to treat patients with plasma rich with COVID-19 antibodies.
The Department of Neurosurgery Grand Rounds: Adaptive Measures for COVID-19
Neurosurgeons from Italy and Taiwan discuss measures taken around COVID-19